FDA further restricts pain medication use in kids

April 21, 2017

U.S. regulators are strengthening warnings about the dangers of two types of powerful painkillers due to risks of slowed breathing and death.

The Food and Drug Administration said Thursday it is requiring makers of prescription versions of the medicines, codeine and , to change the products' labels to warn against giving them to under age 12, and to limit use in older children. The FDA also said breastfeeding women shouldn't take them because of possible harm to the baby.

Many of the products containing these drugs are only available by prescription, but several over-the-counter cough medicines contain codeine. The FDA urged parents to carefully read labels of nonprescription to avoid codeine and to consult a doctor or pharmacist if needed.

The agency in 2013 had warned against use of codeine and tramadol in children and adolescents to treat pain after surgery to remove tonsils.

On Thursday, FDA said that some children are at higher risk of harm from the medicines because they break down codeine and tramadol more rapidly than normal, which can cause dangerously high levels of the drugs in the blood.

That can cause symptoms such as low or shallow breathing, confusion and, in breastfeeding infants, trouble breastfeeding and limpness.

"They are powerful, effective medicines when they're used right. They can cause a lot of harm when they're not," said the FDA's Dr. Douglas Throckmorton during a conference call.

Throckmorton said that the agency was both increasing restrictions on the products' labels and issuing a warning to consumers and pediatricians because of new information and concerns about the drugs' risks.

The FDA has been reviewing the safety of codeine and tramadol for a few years, including combing through reports about patients harmed dating to 1969.

From then until May of 2015, the agency identified 24 deaths and 40 other cases of serious in children under 18 taking medicines containing . It also identified three deaths and six other cases of serious breathing problems reported between January 1969 and March 2016 in children taking tramadol.

Most of those cases occurred in children under 12, and some happened after just one dose of the .

Explore further: Codeine risky for kids after certain surgeries, FDA says

Related Stories

Codeine risky for kids after certain surgeries, FDA says

February 21, 2013
(HealthDay)—Children who are given codeine for pain relief after surgery to remove tonsils or adenoids are at risk for overdose and death, U.S. health officials said Thursday.

MDs strengthen advice against codeine for kids' coughs, pain

September 19, 2016
The American Academy of Pediatrics has strengthened its warnings about prescribing codeine for children because of reports of deaths and risks for dangerous side effects including breathing problems.

US warns about use of codeine in children

August 15, 2012
(AP) — The U.S. Food and Drug Administration warned physicians and caregivers on Wednesday about the risks of giving the pain reliever codeine to children who have just had surgery to treat obstructive sleep apnea.

Doctors issue warning over cough medicines that contain codeine

December 22, 2015
An article in the online journal BMJ Case Reports describes the first published case of confusional state in a healthy 14-year-old girl attributed to excessive consumption of over the counter cough medicine that contained ...

Tramadol associated with increased risk of hospitalization for hypoglycemia

December 8, 2014
The opioid pain-reliever tramadol appears to be associated with an increased risk of hospitalization for hypoglycemia, a potentially fatal condition caused by low blood sugar, according to a report published online by JAMA ...

Recommended for you

Opioids given too easily to children: study

July 16, 2018
(HealthDay)—Many children are prescribed powerful opioid painkillers they don't really need, putting them and those around them at risk, a new study shows.

Study reveals opioid patients face multiple barriers to treatment

July 12, 2018
In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found.

Report details possible conflict of interest issues for FDA advisors

July 6, 2018
Charles Piller, a contributing correspondent for the journal Science, has published a Feature piece in the journal detailing what he describes as possible conflicts of interest issues by people who serve as advisors to the ...

Opioid epidemic responses overlook gender

July 5, 2018
Yale health experts warn that current efforts to confront the growth of opioid addiction and overdose deaths must better incorporate an understanding of how women fit into this epidemic.

Study finds no strong evidence that cannabis reduces chronic pain

July 4, 2018
A four-year study suggests medicinal cannabis is not as effective at relieving chronic non-cancer pain as commonly assumed.

Expanding primary care buprenorphine treatment could curb opioid overdose crisis

July 4, 2018
Expanding the availability of medication treatment for opioid use disorder in primary care settings would be a major step toward reducing overdose deaths, write two physicians specializing in addiction medicine and health ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.